{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:32:15Z","timestamp":1793334735545,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaci.2025.03.019","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T18:24:06Z","timestamp":1743963846000},"page":"150-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["TNF-\u03b1 counters skin inflammation by restraining mast cell\u2013dependent thymic stromal lymphopoietin production"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8423-0844","authenticated-orcid":false,"given":"Davender","family":"Redhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margitta","family":"Worm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4500-7615","authenticated-orcid":false,"given":"Magda","family":"Babina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.03.019_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2249.2011.04375.x","article-title":"The tumour necrosis factor\/TNF receptor superfamily: therapeutic targets in autoimmune diseases","volume":"164","author":"Vinay","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","article-title":"Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey","volume":"119","author":"Aggarwal","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.03.019_bib3","doi-asserted-by":"crossref","DOI":"10.3410\/M1-30","article-title":"The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities","volume":"1","author":"Yost","year":"2009","journal-title":"F1000 Med Rep"},{"key":"10.1016\/j.jaci.2025.03.019_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3892\/br.2012.42","article-title":"TNF inhibitor therapy for rheumatoid arthritis","volume":"1","author":"Ma","year":"2013","journal-title":"Biomed Rep"},{"key":"10.1016\/j.jaci.2025.03.019_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.iac.2017.01.012","article-title":"Adverse reactions to biologic therapy","volume":"37","author":"Patel","year":"2017","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2025.03.019_bib6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists","volume":"156","author":"Lee","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2025.03.019_bib7","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jaci.2022.10.023","article-title":"Novel insights into atopic dermatitis","volume":"151","author":"Schuler","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.ajpath.2015.02.005","article-title":"Mast cells are dispensable in a genetic mouse model of chronic dermatitis","volume":"185","author":"Sulcova","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2025.03.019_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \u201ctunable\u201d effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/exd.14182","article-title":"MRGPRX2 signals its importance in cutaneous mast cell biology: does MRGPRX2 connect mast cells and atopic dermatitis?","volume":"29","author":"Wang","year":"2020","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2025.03.019_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087021","article-title":"The role of mast cells in the induction and maintenance of inflammation in selected skin diseases","volume":"24","author":"Wo\u017aniak","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2025.03.019_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/all.13239","article-title":"Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis","volume":"73","author":"Furue","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.03.019_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212365","article-title":"Connections between immune-derived mediators and sensory nerves for itch sensation","volume":"22","author":"Toyama","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2025.03.019_bib14","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaci.2023.08.017","article-title":"Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms, and therapeutic targets in atopic diseases","volume":"153","author":"Kim","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib15","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1111\/febs.14465","article-title":"Interactions of the immune and sensory nervous systems in atopy","volume":"285","author":"Oetjen","year":"2018","journal-title":"FEBS J"},{"key":"10.1016\/j.jaci.2025.03.019_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810871","article-title":"How \u201cneuronal\u201d are human skin mast cells?","volume":"23","author":"Babina","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2025.03.019_bib17","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1084\/jem.184.4.1397","article-title":"Immune and inflammatory responses in TNF alpha\u2013deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response","volume":"184","author":"Pasparakis","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.03.019_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1084\/jem.20031975","article-title":"A role for thymic stromal lymphopoietin in CD4+ T cell development","volume":"200","author":"Al-Shami","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.03.019_bib19","doi-asserted-by":"crossref","first-page":"10898","DOI":"10.1073\/pnas.0504834102","article-title":"The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb","volume":"102","author":"Harfe","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2025.03.019_bib20","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1038\/jid.2008.84","article-title":"Systemic PPARgamma ligation inhibits allergic immune response in the skin","volume":"128","author":"Dahten","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.03.019_bib21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/bjd.13465","article-title":"Thymic stromal lymphopoietin induction by skin irritation is independent of tumour necrosis factor-\u03b1, but supported by interleukin-1","volume":"172","author":"Kumari","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2025.03.019_bib22","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20082242","article-title":"Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome","volume":"206","author":"Briot","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.03.019_bib23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cyto.2011.03.007","article-title":"Thymic stromal lymphopoietin is expressed and produced by caspase-1\/NF-\u03baB pathway in mast cells","volume":"54","author":"Moon","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.jaci.2025.03.019_bib24","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.jaci.2022.02.025","article-title":"Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation, and activation that persists in remission","volume":"149","author":"Ben-Baruch Morgenstern","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142067","article-title":"Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin","volume":"5","author":"Jiang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2025.03.019_bib26","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jaci.2022.01.029","article-title":"Mast cells instruct keratinocytes to produce thymic stromal lymphopoietin: relevance of the tryptase\/protease-activated receptor 2 axis","volume":"149","author":"Redhu","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib27","doi-asserted-by":"crossref","first-page":"132","DOI":"10.12788\/j.sder.0018","article-title":"Immunology of atopic dermatitis: novel insights into mechanisms and immunomodulatory therapies","volume":"32","author":"Harskamp","year":"2013","journal-title":"Semin Cutan Med Surg"},{"issue":"3 pt 1","key":"10.1016\/j.jaci.2025.03.019_bib28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaad.2004.11.022","article-title":"Infliximab in the treatment of moderate to severe atopic dermatitis","volume":"52","author":"Jacobi","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2025.03.019_bib29","first-page":"2506","article-title":"Atopic dermatitis as a side effect of anti\u2013tumor necrosis factor-alpha therapy","volume":"30","author":"Mangge","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaci.2025.03.019_bib30","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3109\/00365521.2015.1125524","article-title":"Infliximab-induced skin manifestations in patients with inflammatory bowel disease","volume":"51","author":"Hellstr\u00f6m","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jaci.2025.03.019_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M15-0729","article-title":"Characteristics of skin lesions associated with anti\u2013tumor necrosis factor therapy in patients with inflammatory bowel disease: a cohort study","volume":"164","author":"Cleynen","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2025.03.019_bib32","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/eji.200526119","article-title":"Novel tumor necrosis factor\u2013knockout mice that lack Peyer\u2019s patches","volume":"35","author":"Kuprash","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib33","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.4049\/jimmunol.168.4.2020","article-title":"Development of atopic dermatitis-like skin lesions in STAT6-deficient NC\/Nga mice","volume":"168","author":"Yagi","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jid.2023.06.201","article-title":"Mast cells initiate type 2 inflammation through tryptase released by MRGPRX2\/MRGPRB2 activation in atopic dermatitis","volume":"144","author":"Jia","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.03.019_bib35","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1586\/14789450.2013.814881","article-title":"Epidermal TSLP: a trigger factor for pathogenesis of atopic dermatitis","volume":"10","author":"Indra","year":"2013","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.jaci.2025.03.019_bib36","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/jdv.19911","article-title":"Proteomic, miRNA and bacterial biomarker patterns in atopic dermatitis patients and their course upon anti-IL-4R\u03b1 therapy","volume":"38","author":"Pa\u017eur","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2025.03.019_bib37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-0846.2011.00509.x","article-title":"Side-by-side comparison of an open-chamber (TM 300) and a closed-chamber (Vapometer\u2122) transepidermal water loss meter","volume":"17","author":"Steiner","year":"2011","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.jaci.2025.03.019_bib38","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1084\/jem.20041503","article-title":"Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin","volume":"202","author":"Yoo","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.03.019_bib40","first-page":"119","article-title":"Thymic stromal lymphopoietin production induced by skin irritation results from concomitant activation of protease-activated receptor 2 and interleukin 1 pathways","volume":"182","author":"Redhu","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2025.03.019_bib41","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.immuni.2019.03.013","article-title":"Activation of mast-cell\u2013expressed Mas-related G-protein\u2013coupled receptors drives non-histaminergic itch","volume":"50","author":"Meixiong","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.03.019_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176311","article-title":"Mast cells limit ear swelling independently of the chymase mouse mast cell protease 4 in an MC903-induced atopic dermatitis-like mouse model","volume":"21","author":"Svanberg","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2025.03.019_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00136-8","article-title":"Keratinocytes and cytokines","volume":"88","author":"Gr\u00f6ne","year":"2002","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.jaci.2025.03.019_bib44","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1084\/jem.172.6.1609","article-title":"Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light","volume":"172","author":"K\u00f6ck","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.03.019_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1239598","article-title":"\u201cInput\/output cytokines\u201d in epidermal keratinocytes and the involvement in inflammatory skin diseases","volume":"14","author":"Morizane","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib46","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.4049\/jimmunol.176.3.1431","article-title":"Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2","volume":"176","author":"Johansen","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib47","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1159\/000485288","article-title":"TNF-\u03b1 regulates mast cell functions by inhibiting cell degranulation","volume":"44","author":"Gao","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.jaci.2025.03.019_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-2478(98)00106-0","article-title":"Tumor necrosis factor alpha (TNF-alpha) modulates rat mast cell reactivity","volume":"64","author":"Olejnik","year":"1998","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2025.03.019_bib49","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20187065","article-title":"TNF-\u03b1 inhibits SCF, ghrelin, and substance P expressions through the NF-\u03baB pathway activation in interstitial cells of Cajal","volume":"51","author":"Ren","year":"2018","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.jaci.2025.03.019_bib50","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/cells8080829","article-title":"Thymic stromal lymphopoietin interferes with the apoptosis of human skin mast cells by a dual strategy involving STAT5\/Mcl-1 and JNK\/Bcl-x(L)","volume":"8","author":"Hazzan","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2025.03.019_bib51","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20062211","article-title":"Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells","volume":"204","author":"Allakhverdi","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.03.019_bib52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1378\/chest.11-1782","article-title":"Mast cell\u2013airway smooth muscle crosstalk: the role of thymic stromal lymphopoietin","volume":"142","author":"Kaur","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2025.03.019_bib53","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.jaci.2013.08.052","article-title":"Increased density of intraepithelial mast cells in patients with exercise-induced bronchoconstriction regulated through epithelially derived thymic stromal lymphopoietin and IL-33","volume":"133","author":"Lai","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.03.019_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010102","article-title":"Thymic stromal lymphopoietin promotes MRGPRX2-triggered degranulation of skin mast cells in a STAT5-dependent manner with further support from JNK","volume":"10","author":"Babina","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2025.03.019_bib55","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1182\/blood-2013-02-483792","article-title":"Redefinition of the human mast cell transcriptome by deep-CAGE sequencing","volume":"123","author":"Motakis","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2025.03.019_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105518","article-title":"Overlapping features of psoriasis and atopic dermatitis: from genetics to immunopathogenesis to phenotypes","volume":"23","author":"Tsai","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2025.03.019_bib57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000509716","article-title":"Different innate immune responses in BALB\/c and C57BL\/6 strains following corneal transplantation","volume":"13","author":"Bleul","year":"2021","journal-title":"J Innate Immun"},{"key":"10.1016\/j.jaci.2025.03.019_bib58","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.ajpath.2016.04.017","article-title":"Pathological type-2 immune response, enhanced tumor growth, and glucose intolerance in Retnl\u03b2 (RELM\u03b2) null mice: a model of intestinal immune system dysfunction in disease susceptibility","volume":"186","author":"Wernstedt Asterholm","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaci.2025.03.019_bib59","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1172\/JCI1647","article-title":"Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice","volume":"101","author":"Spergel","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.03.019_bib60","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1365-2222.2010.03472.x","article-title":"Tamoxifen counteracts the allergic immune response and improves allergen-induced dermatitis in mice","volume":"40","author":"Babina","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.03.019_bib61","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/jid.2011.296","article-title":"Vitamin D receptor activation improves allergen-triggered eczema in mice","volume":"132","author":"Hartmann","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.03.019_bib62","first-page":"29","article-title":"Systemic sensitization with the protein allergen ovalbumin augments local sensitization in atopic dermatitis","volume":"7","author":"Yoo","year":"2014","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jaci.2025.03.019_bib63","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1172\/JCI8624","article-title":"Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4","volume":"105","author":"Herrick","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.03.019_bib64","first-page":"389","article-title":"Translational animal models of atopic dermatitis for preclinical studies","volume":"90","author":"Martel","year":"2017","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.jaci.2025.03.019_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005374","article-title":"TSLP elicits IL-33\u2013independent innate lymphoid cell responses to promote skin inflammation","volume":"5","author":"Kim","year":"2013","journal-title":"Sci Transl Med"}],"updated-by":[{"DOI":"10.1016\/j.jaci.2025.07.022","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925003690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925003690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T08:34:03Z","timestamp":1778142843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925003690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0091674925003690"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.03.019","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF-\u03b1 counters skin inflammation by restraining mast cell\u2013dependent thymic stromal lymphopoietin production","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}